Tau PET/CT Imaging for Alzheimer's Disease

Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)

Recruiting Observational Study
Alzheimer's Disease
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 120
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
University of Pennsylvania · Other
Who this trial is looking for

This trial is looking for older adults with Mild Cognitive Impairment or Alzheimer's Disease. Participants will undergo a Tau PET/CT scan and provide information about their health and memory.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am enrolled in the MPC study.
  • I have a reliable study partner to come with me to the scan.
  • I have had a brain MRI within the last 6 months.

You may not be able to join if

  • I have medical or psychiatric conditions that could affect my safety.
  • I have structural brain problems like major stroke or a mass on my MRI.
  • I cannot tolerate or have a contraindication to imaging procedures.
  • I have a history of significant ongoing alcohol or substance abuse.
  • I am a female of child-bearing age.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

To collect Tau PET/CT imaging in older adults diagnosed with Mild Cognitive Impairment (MCI) or Alzheimer's Disease (AD) in the Mismatch Prospective Cohort Study (MPC-Tau) study to determine relationship to clinical, cognitive, and other biomarker data. Findings from this study will likely provide insight into the phenotypic variability of Alzheimer's Disease and other related pathologies.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Enrolled in MPC study (Protocol 850160 at UPenn; Protocol 2022P002447 at MGH). 2. Reliable study partner to accompany participant to the PET/CT scan 3. A brain MRI must be performed within 6 months prior to their study AV-1451 TAU PET/CT scan date and be deemed of adequate qu…
Contacts

Jacqueline Lane

610-299-1243

Jacqueline.Lane@pennmedicine.upenn.edu

CONTACT